Celldex Therapeutics | CLDX - Cash And Equivalent

Stock Price
23.55
Daily Change
-0.72 -2.97%
Monthly
-8.01%
Yearly
-1.83%
Q1 Forecast
23.84

Celldex Therapeutics reported $36.04M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
AbbVie USD 5.63B 838M Sep/2025
Amgen USD 9.13B 316M Dec/2025
Bristol-Myers Squibb USD 15.73B 3.13B Sep/2025
Celldex Therapeutics USD 36.04M 12.99M Sep/2025
Glaxosmithkline GBP 3.3B 303M Sep/2025
Pfizer USD 1.34B 295M Sep/2025
Roche Holding CHF 7.55B 579M Jun/2025